Nachrichten

GeneNovate: Empowering Innovators and Entrepreneurs in Gene and Cell Therapies

© UnternehmerTUM / TUM Venture Labs Healthcare

Get excited for and improve your knowledge about entrepreneurship with this national workshop series of the GCT - nationale Strategie Gen- und Zellbasierte Therapien.

In 2024 the Berlin Institute of Health, the UnternehmerTUM / TUM Venture Labs Healthcare in Munich and the Universitätsmedizin Mainz are piloting the first education program.

You are a ...
PhD, PostDoc in Medicine, LifeScience, Biotech, Bioinformatics, MedTech, Digital Health

You focus on ...
Biotech: Gene- & Cell Therapies & Companion Diagnostics

and are interested to participate in the program pilot to

... actively shaping the future and developing your entrepreneurial skills?
... working out a solution idea and working in an interdisciplinary team?
... getting accompanied by excellent mentors and trainers?

Then apply until 31 December 2023 with a short letter of motivation and your CV here: https://crqs.de/ObOhtoGo

Please find more information in the GeneNovate-Flyer.

You will also find an overview on the German cooperation program and Introduction to GeneNovate in this presentation.

GeneNovate is a joint initiative by the Berlin Institute of Health, the UnternehmerTUM / TUM Venture Labs Healthcare in Munich and the Universitätsmedizin Mainz to promote healthcare entrepreneurship!